Dr. Ihsan Al-Khalil, MD

Media Releases

Get to know Pediatric Hematologist-Oncologist Dr. Ihsan Al-Khalil, who serves patients in Lumberton, North Carolina.

Dr. Al-Khalil is a fellowship-trained pediatric hematologist-oncologist with over five decades of experience in his field. He sees patients at Southeastern Family Medicine Residency Clinic in Lumberton, North Carolina.

With an unwavering commitment to his speciality, he is board-certified in pediatrics and pediatric hematology-oncology by the American Board of Pediatrics (ABP). The mission of the ABP is to advance child health by certifying pediatricians who meet standards of excellence and are committed to continuous learning and improvement.

A 1972 graduate of the University of Damascus, Faculty of Medicine in Syria, Dr. Al-Khalil relocated to the United States to complete his training. He performed his internship at Iowa Methodist Medical Center and his residency in pediatrics at the Medical College of Ohio at Toledo. Wanting to further his education, he completed his fellowships in pediatric hematology-oncology at the University of Connecticut and Yale-New Haven Hospital.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease. More specifically, a pediatric hematologist-oncologist treats children and teens from birth through young adulthood.

Among the doctor’s most notable achievements, he is the recipient of Patients’ Choice Award (2016, 2017) and Compassionate Doctor Recognition (2016, 2017).

Recommended Articles

• How is Multiple Myeloma Diagnosed?

  Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...

• Lymphoma: The Importance of a Support System & Communication

  Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• Facts About Multiple Myeloma

  Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...

• The Blow Self-Image Can Take During Lymphoma Treatment

  Many who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...

• The Promising Future of Gene Therapy and Lymphoma

  Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...